QC
RVMD icon

Quadrature Capital’s Revolution Medicines RVMD Stock Holding History

Quadrature Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4M Buy
92,717
+76,050
+456% +$11.1M 0.15% 118
2026
Q1 		$1.62M Buy
+16,667
New +$1.68M 0.02% 436
2025
Q4 		– Sell
-17,874
Closed -$835K – 1592
2025
Q3 		$835K Buy
+17,874
New +$700K 0.01% 413
2025
Q2 		– Sell
-5,729
Closed -$203K – 1421
2025
Q1 		$203K Buy
+5,729
New +$233K ﹤0.01% 857

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Quadrature Capital's RVMD Position: Q2 2026 in Review

Quadrature Capital increased its Revolution Medicines (RVMD) stake by 456% in Q2 2026, buying an estimated $11.1M and bringing the position to 92,717 shares worth $17.4M. The position accounts for 0.15% of the portfolio, ranked #118.

Quadrature Capital first reported a position in RVMD in Q1 2025 and has held it in 4 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Quadrature Capital held 92,717 shares of Revolution Medicines worth $17.4M as of Q2 2026.
  • Quadrature Capital bought 76,050 Revolution Medicines shares in Q2 2026, an estimated $11.1M.
  • Revolution Medicines made up 0.15% of Quadrature Capital's portfolio in Q2 2026, its #118 holding.
  • Quadrature Capital first reported a position in Revolution Medicines in Q1 2025 and has held it in 4 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.